DGX · NYSE · STOCK
Quest Diagnostics (DGX) Stock Analysis
$231.00
52W $171.18 – $248.84
61/100
$25.49B
24.2
0.54
Is DGX Bullish or Bearish?
Bullish.
Innellis AI committee rates Quest Diagnostics (DGX) Buy with a composite score of 61/100
, based on 5 analysts with 60% agreement.
Last updated October 10, 2026.
What Would Change This View
- Upgrade to Strong Buy
- Requires a committee score of 75.0 — +14.17 from today. Applies on the first day at or above the line; upgrades are never dampened.
- Downgrade to Watch
- Requires the score to fall below 55.0 — -5.83 from today. The band boundary is 60.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.
Executive Summary
The primary driver is 5 consecutive earnings beats -- consistent execution. The main limiting factor is sector concentration is already high (hhi 2796.97). The committee is constructive but not yet at full conviction.
Bull & Bear Case
Bull Case
- 5 consecutive earnings beats -- consistent execution — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- News sentiment is positive (+0.23 across 13 articles, 14d) — News
Bear Case
- MACD histogram negative -- bearish momentum — Technical
Both cases are generated from quantitative data signals, not qualitative or
forward-looking judgement. They summarise what the numbers say today.
Price History (6M)
AI Investment Committee
Committee Consensus
As of October 10, 2026
Overall Committee Score
61/100
Agreement
60%
Analysts
5
Conviction
Moderate
Sector Rank
Top 29%
of 192 Healthcare peers
Value Analyst
neutral
58
/ 100 · Moderate confidence
Fair value -- neither a bargain nor obviously overpriced
Growth Analyst
bullish
68
/ 100 · High confidence
Strong, accelerating growth with consistent execution
+ 5 consecutive earnings beats -- consistent execution
Technical Analyst
neutral
48
/ 100 · High confidence
Mixed or range-bound price action
− MACD histogram negative -- bearish momentum
Macro Analyst
bullish
65
/ 100 · Low confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
News Analyst
bullish
65
/ 100 · Low confidence
News flow and recent filings/analyst actions are net positive
+ News sentiment is positive (+0.23 across 13 articles, 14d)
Portfolio Manager
bearish
30
/ 100 · Moderate confidence
The existing book itself argues for caution here, independent of how good this specific stock looks
− Sector concentration is already high (HHI 2796.97)
Investment Thesis Evolution
Committee score moved marginally from 61.2 to 60.8.
- Bullish support removed: 1 signal(s) disappeared.
- New bullish signals: 1 appeared.
Analyst-level changes:
- News Analyst: +1 bullish signal(s).
Comparing 2026-10-09 to 2026-10-10 (1 day apart).
Technical Analysis
RSI (14)
43.9
Neutral
MACD Histogram
-0.862
Bearish Momentum
Trend Direction
Sideways
Weekly: Uptrend
Market Structure
Hh Hl
Bollinger %B
0.30
Inside Bands
Price vs Moving Averages
EMA 9
$231.50
Below
EMA 21
$234.09
Below
EMA 50
$232.64
Below
EMA 200
$211.81
Above
Fundamental Analysis
Valuation
63
Growth
87
Profitability
52
Financial Health
74
Cash Flow
70
Valuation
P/E Ratio
24.2×
P/B Ratio
3.38×
PEG Ratio
1.92
Dividend Yield
1.46%
52W High
$248.84
52W Low
$171.18
Quality & Growth
ROE
1383.5%
ROA
611.4%
Gross Margin
3314.9%
Operating Margin
1414.4%
Revenue Growth YoY
—
Debt / Equity
0.85
AI Fundamental Assessment
P/E ratio of 24.2 (inexpensive relative to a 15-40x range); Price-to-book of 3.4x; PEG ratio of 1.9 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 13.8%; Return on assets of 6.1%; Net margin of 9.2%; Gross margin of 33.1%; Current ratio of 1.59 (healthy short-term liquidity); Debt-to-equity of 0.85; Free cash flow per share is positive (11.09); Most recent quarter beat estimates by 9.3%; 5 consecutive earnings beats; EPS growth accelerating (+3.3% -> +24.8% QoQ); Average YoY EPS growth of 19.1%; Analyst estimates rising over recent quarters
Get the Full DGX Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →